<i>Lactobacillus plantarum</i> and <i>Lactobacillus brevis</i> Alleviate Intestinal Inflammation and Microbial Disorder Induced by ETEC in a Murine Model

Han, Xuebing; Ding, Sujuan; Ma, Yong; Fang, Jun; Jiang, Hongmei; Li, Yi; Liu, Gang

doi:https://doi.org/10.1155/2021/6867962

Oxidative Medicine and Cellular Longevity

On this page

Abstract Introduction Materials and Methods Results Discussion Conclusion Data Availability Conflicts of Interest Acknowledgments References Copyright Related Articles

Special Issue

The Role of Redox Homeostasis in Cancer Biology and Anticancer Therapy 2021

View this Special Issue

Research Article | Open Access

Volume 2021 | Article ID 6867962 | https://doi.org/10.1155/2021/6867962

Lactobacillus plantarum and Lactobacillus brevis Alleviate Intestinal Inflammation and Microbial Disorder Induced by ETEC in a Murine Model

Xuebing Han,¹Sujuan Ding,¹Yong Ma,¹Jun Fang,¹Hongmei Jiang,¹Yi Li,¹and Gang Liu¹

Academic Editor: Guoku Hu

Received10 Jul 2021

Accepted20 Aug 2021

Published21 Sept 2021

Abstract

The purpose of this research is to explore the positive effects of Lactobacillus plantarum and Lactobacillus brevis on the tissue damage and microbial community in mice challenged by Enterotoxigenic Escherichia coli (ETEC). Twenty-four mice were divided into four groups randomly: the CON group, ETEC group, LP-ETEC group and LB-ETEC group. Our results demonstrated that, compared with the ETEC group, the LP-ETEC and LB-ETEC groups experienced less weight loss and morphological damage of the jejunum. We measured proinflammatory factors of colonic tissue and found that L. plantarum and L. brevis inhibited the expression of proinflammatory factors such as IL-β, TNF-α, and IL-6 and promoted that of the tight junction protein such as claudin-1, occludin, and ZO-1. Additionally, L. plantarum and L. brevis altered the impact of ETEC on the intestinal microbial community of mice, significantly increased the abundance of probiotics such as Lactobacillus, and reduced that of pathogenic bacteria such as Proteobacteria, Clostridia, Epsilonproteobacteria, and Helicobacter. Therefore, we believe that L. plantarum and L. brevis can stabilize the intestinal microbiota and inhibit the growth of pathogenic bacteria, thus protecting mice from the gut inflammation induced by ETEC.

1. Introduction

Diarrhea induced by Enterotoxigenic Escherichia coli (ETEC) is a major challenge to newborn piglets and weaned piglets. The condition increases occurrences of morbidity and mortality, which results in huge economic losses in the global swine industry [1]. ETEC can colonize in the small intestine, increase the expression of proinflammatory factors, cause intestinal barrier damage, and eventually lead to the development of intestinal inflammation [2–4]. Previous studies have proven that probiotics are vital to prevent and treat cancer [5], inflammatory bowel disease (IBD) [6], irritable bowel syndrome [7], and other diseases. In addition, probiotics can counteract the inflammation caused by ETEC [8, 9]. Most notably, probiotics are considered the only effective feed additives that protect against pathogens. In view of the injury and economic losses caused by intestinal inflammation such as diarrhea, colorectal cancer, and IBD, it is necessary to study probiotics, which are used as feed additives to inhibit pathogens and promote intestinal health.

Lactic acid bacteria, a kind of probiotic that exists in human and animal intestines, can enhance the immune system by inhibiting the expression of proinflammatory cytokines or promoting that of anti-inflammatory cytokines [10, 11]. Lactobacillus plantarum is a major species of lactic acid bacteria, with a variety of probiotic characteristics, gastrointestinal transport tolerance, and anti-inflammatory properties [12]. Previous studies have shown that the supplementation of L. plantarum in the diet can promote the gastrointestinal health of weaned piglets [13] and improve the antioxidant status and growth performance of piglets [14]. It is worth noting that studies on the effect of L. plantarum on various cancers are also being actively carried out [15, 16]. As a close relative of L. plantarum, L. brevis also has a variety of probiotic characteristics, including tolerance to acid and bile, adhesion to intestinal cells, and the ability to survive through the gastrointestinal tract [17, 18]. These characteristics of L. brevis enable it to maintain the homeostasis of the intestine, improve the barrier function of intestinal epithelium under oxidative stress, and reduce intestinal inflammation in the mouse model [19, 20].

In this study, ETEC was used to induce intestinal inflammation in a mouse model. And we explored the protective effects of L. plantarum and L. brevis on the injury induced by ETEC in the murine model, observed the changes in the amounts of cytokines and tight junction proteins, and determined the effects of these two probiotics on intestinal flora.

2. Materials and Methods

2.1. Bacteria

The strains Lactobacillus plantarum GL17, Lactobacillus brevis AY858, and Enterotoxigenic Escherichia coli used in this study were stored in Hunan Agricultural University (Changsha, China). L. plantarum GL17 and L. brevis AY858 were cultured in MRS broth at 37°C for 24 hours, while ETEC was cultured in a Luria-Bertani liquid medium at 37°C for the same time. To quantify the colonies, the cultured bacterial fluid was transferred to the corresponding solid medium and incubated at 37°C for 24 hours. Then, the bacterial samples of both probiotics and ETEC were centrifuged and suspended in sterile normal saline solution at and , respectively.

2.2. Animals and Experimental Design

The experiment was approved by the Animal Care and Use Committee of Hunan Agricultural University. Twenty-four eight-week-old ICR mice from the Shanghai Laboratory Animal Central (Changsha, China) were housed in a pathogen-free environment for seven days of adaptation. Then, the mice were divided into four groups randomly: the control group (CON), the ETEC group (ETEC), the L. plantarum GL17 treatment group (LP-ETEC), and the L. brevis AY858 treatment group (LB-ETEC). There were six mice in each group, and the basic diet and water for all mice were not limited. The experiment lasted for 21 days (Figure 1(a)). During the first 14 days of the experiment, the LP-ETEC group and the LB-ETEC group were given L. plantarum GL17 and L. brevis AY858, respectively, by gavage every day, while the control group and the ETEC group were given sterile saline every day. From the 15th day of the experiment, the ETEC group, LP-ETEC group, and LB-ETEC group were given ETEC by gavage until the end of the experiment. On the 21st day, all mice were killed, and a part of the jejunum was fixed in paraformaldehyde for histomorphological analysis, while the contents of the colon were collected and frozen in liquid nitrogen for the determination of microbial diversity.

(a)

(b)

2.3. Jejunum Histopathology

The jejunum samples fixed in the paraformaldehyde were dehydrated using ethanol gradient and embedded in paraffin. The samples were then stained with hematoxylin and eosin and observed under a microscope. The specific process is in accordance with methods used in previous research [21].

2.4. qPCR

The total RNA of frozen colonic tissue was extracted by TRIzol (Invitrogen, USA) according to the instruction. To determine the concentration of the extracted RNA, DNase I was used to treat RNA, and then, the concentration was determined by spectrophotometer at 260 nm. The primers used in the experiment are shown in Table 1, and the specific methods refer to a previous experiment [22]. Finally, the amplification reaction was carried out, and the calculation formula used to determine gene expression level refers to Ma et al. [23].

2.5. 16S Ribosomal RNA Amplicon Sequencing

To determine the diversity of microorganisms in the colonic contents, the microbial genomic DNA of colon contents was extracted by using the QIAamp DNA Stool Mini Kit firstly. Then, the concentration and purity of DNA were detected on 1% agarose gel, and the primers 357F (5-ACTCCTACGGRAGGCAGCAG-3) and 806R (5-GGACTACHVGGGTWTCTAAT-3) were used to amplify the V3-V4 region of 16S rDNA. After recovery and purification of PCR products, the library was prepared for sequencing analysis. Finally, the quality of off-machine data was controlled and optimized, and the composition of microbial communities was determined by OTU clustering. Moreover, the α diversity analysis was performed by mothur (Version 1.33.3).

2.6. Data Analysis

All of the data in the experiment are expressed as (SD) and analyzed by one-way ANOVA and Tukey’s multiple comparison test to compare the differences between the four groups (SPSS 21 software). value < 0.05 was regarded as a significant difference.

3. Results

3.1. L. plantarum and L. brevis Inhibit the Weight Loss Induced by ETEC

The results of weight are shown in Figure 1(b). Compared with the CON group, ETEC reduced the weight of mice significantly (). When treated with L. plantarum GL17 and L. brevis AY858, the weight of mice increased significantly (). The results showed that these two probiotics reduced weight loss in the mice.

3.2. L. plantarum and L. brevis Inhibit the Development of Intestinal Injury Induced by ETEC

The results of histologic examination (Figure 2) showed that the height of jejunal villi decreased significantly () and the crypt depth increased significantly () after ETEC attack. Compared with the ETEC group, the mice in the LP-ETEC group had increased villus heights and reduced crypt depth significantly (). Similar results were observed in the LB-ETEC group, with a slight increase in villus heights and a significant decrease in crypt depth (). These results indicated that both of those two probiotics can reduce the intestinal damage caused by ETEC, especially L. plantarum GL17, which made the LP-ETEC group return to the same level as the CON group.

(a)

(b)

(c)

(d)

(e)

(f)

3.3. L. plantarum and L. brevis Affect Inflammation and Intestinal Barrier

The expressions of cytokines in the colonic tissues were measured (Figures 3(a)–3(f)). Compared with the CON group, lysozyme and cryptidin in the ETEC group decreased significantly (), while no significant difference was observed in that of IL-1β, TNF-α, IL-6, and A20. When treated with L. plantarum GL17, lysozyme and cryptidin increased significantly (). Similarly, after the treatment of L. brevis AY858, a significant increase in lysozyme and cryptidin () and a significant decrease in IL-6 () were observed.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

The expression of tight junction proteins is shown in Figures 3(g)–3(i). When attacked by ETEC, claudin-1 and occludin decreased significantly (), while ZO-1 remained almost unchanged. L. plantarum GL17 increased claudin-1 and occludin slightly, but there was no significant difference compared with the ETEC group. Similarly, no significant difference was observed in occludin between the LB-ETEC group and the ETEC group. However, compared with the ETEC group, claudin-1 in the LB-ETEC group increased significantly ().

3.4. L. plantarum and L. brevis Regulate Intestinal Microbes in Mice

The results of intestinal microorganism diversity are shown in Figure 4. After the ETEC challenge, the Sobs index, Shannon index, Simpson index, and PD-whole-tree index decreased significantly (). After the treatment of L. plantarum GL17 and L. brevis AY858, these indexes increased and returned to normal level, especially the Sobs index and Simpson index, which were significantly different from those of the ETEC group (). Furthermore, the Shannon index in the LB-ETEC group and the PD-whole-tree index in the LP-ETEC group were significantly different from those in the ETEC group (). Therefore, both of these two probiotics have obvious protective effects on ETEC-induced decline of intestinal microbial diversity in mice.

(a)

(b)

(c)

(d)

At the phylum level, there are nine kinds of microorganisms in each of four groups, of which Bacteroidetes, Firmicutes, and Proteobacteria accounted for more than 86% of all microorganisms (Figure 5(a)). The abundance of Bacteroidetes in the CON, ETEC, LP-ETEC, and LB-ETEC groups was 62.1485%, 42.3336%, 43.6535%, and 53.8593%, respectively. Firmicutes accounted for 26.6949%, 40.0591%, 46.6572%, and 33.6746%, respectively. The Proteobacteria abundance was 8.4628%, 14.4314%, 6.6691%, and 8.7466%, respectively. After being challenged by ETEC, Bacteroidetes in mice decreased significantly (). In contrast, the abundance of Proteobacteria showed the opposite trend, which was significantly higher than that of the CON group () (Figures 5(b) and 5(c)). However, when treated with L. plantarum GL17 and L. brevis AY858, Proteobacteria in mice decreased significantly ().

(a)

(b)

(c)

The abundance of Bacteroidia, Clostridia, and Bacilli accounted for more than 80% of all microorganisms in the class level (Figure 6(a)). The abundance of Bacteroidia in the CON, ETEC, LP-ETEC, and LB-ETEC groups was 52.562%, 49.0004%, 52.9771%, and 51.7049%, respectively. Clostridia accounted for 16.7878%, 23.7975%, 14.2299%, and 14.7012%, respectively. The Bacilli abundance was 11.3105%, 10.0499%, 17.1775%, and 16.7497%, respectively. After being attacked by ETEC, the abundance of Clostridia and Epsilonproteobacteria increased, especially Epsilonproteobacteria, which increased significantly () (Figures 6(b) and 6(c)). However, both L. plantarum GL17 and L. brevis AY858 significantly reduced the abundance of Clostridia and Epsilonproteobacteria ().

(a)

(b)

(c)

As for the order level, the abundance of Bacteroidales, Clostridiales, and Lactobacillales was the highest in the CON, LP-ETEC, and LB-ETEC groups (Figure 7(a)). The abundance of Bacteroidales in the CON, LP-ETEC, and LB-ETEC groups was 50.562%, 39.1805%, and 39.7049%, respectively. Clostridiales accounted for 17.1168%, 14.2299%, and 16.8516%, respectively. The abundance of Lactobacillales was 17.2176%, 22.0299%, and 21.248%, respectively. However, the top three most abundant microorganisms at the order level in ETEC group were Bacteroidales, Clostridiales, and Campylobacterales, accounting for 49.0004%, 25.221%, and 7.6303%, respectively. Clostridiales in the ETEC group increased significantly () and Lactobacillales in the ETEC group decreased significantly () compared with those in the CON group (Figures 7(b) and 7(c)). After the treatment of L. plantarum GL17 and L. brevis AY858, the abundance of Clostridiales and Lactobacillales had changed significantly ().

(a)

(b)

(c)

Eight representative microbial genera in the four groups were selected and analyzed (Figure 8(a)). In the genus of microorganisms that have been classified, Lactobacillus, Bacteroides, and Helicobacter were the three main microorganisms among the groups of CON, LP-ETEC, and LB-ETEC. The abundance of Lactobacillus in the CON, LP-ETEC, and LB-ETEC groups was 26.08%, 33.5332%, and 27.7802%, respectively. Bacteroides accounted for 7.4573%, 23.1571%, and 9.449%, respectively. The abundance of Helicobacter was 1.486%, 2.9112%, and 3.2437%, respectively. However, the top three most abundant microbial genera in the ETEC group were Bacteroides, Helicobacter, and Alloprevotella, accounting for 5.9428%, 8.0295%, and 4.6711%, respectively. After being challenged by ETEC, the abundance of Lactobacillus reduced significantly (), while that of Helicobacter increased significantly () (Figures 8(b) and 8(c)). However, when treated with L. plantarum GL17 and L. brevis AY858, the abundance of Lactobacillus and Helicobacter changed significantly () and returned to the normal level.

(a)

(b)

(c)

4. Discussion

The protective effects of L. plantarum GL17 and L. brevis AY858 on the injury induced by ETEC were explored in this study. The results showed that both probiotics reduced the weight loss and morphological damage of the jejunum significantly. The expression of cytokines decreased, while that of the tight junction protein increased in mice treated with L. plantarum GL17 and L. brevis AY858. Meanwhile, L. plantarum GL17 and L. brevis AY858 restored the colonic microbial diversity to the normal level in mice challenged by ETEC and increased the relative abundance of Lactobacillus. In contrast, L. plantarum GL17 and L. brevis AY858 reduced the relative abundance of Proteobacteria, Clostridia, Epsilonproteobacteria, and Helicobacter in the colon after ETEC challenge.

The surface of intestinal mucosa, which is the largest surface of the human body, contacts with the external environment continuously [24]. Columnar epithelial cells are arranged into the intestinal epithelium and folded into crypts or concave [25]. These fully differentiated epithelial cells protect the body from potentially harmful microorganisms and viruses in the intestinal microenvironment [26]. Intestinal villi are critical components of the intestine that can increase the absorption area and promote the absorption of nutrients [27]. Endotoxin produced by ETEC can cause a variety of morphological changes of the intestinal tract, such as the increase of mucosal crypt depth, decrease of villus height, and submucosal edema [28]. Probiotics can reduce the morphological damage caused by the endotoxin, which can increase the height of villi and promote the growth of piglets [29, 30]. A previous study has shown that piglets fed with L. plantarum displayed higher villus height and lower crypt depth in the jejunum [1]. The same results were obtained in this experiment. L. plantarum and L. brevis protected the structural integrity of the jejunum, as well as the ability of absorbing nutrients. However, the protective effect of these two probiotics on villi is slightly different; L. plantarum is better than L. brevis at restoring the height of intestinal villi.

ETEC produces heat-labile enterotoxin (LT), and the LTA subunit of it, together with ADP-ribosylation factor, can induce the ribosylation of Gsα [31]. At that time, the adenylate cyclase of the target cell is uncontrolled, converting ATP to cAMP continuously. The increase of cAMP will not only activate the NF-κB signaling pathway and produce a large number of inflammatory factors [32] but also activate the MAPK signaling pathway, resulting in the dislocation of tight junction proteins and impairment of intestinal barrier function [33]. The increase of proinflammatory factors, including IL-1β, TNF-α, and IL-6, will aggravate intestinal inflammation and promote the occurrence of colorectal cancer. In this experiment, although the difference was insignificant, the proinflammatory factors showed an upward trend after ETEC challenge, which indicated that ETEC increased intestinal inflammation in mice. Probiotics can reduce the inflammatory response by reducing the level of cytokines [12, 34, 35], which is also proven by our research. Although the difference was not significant, the proinflammatory factors in mice treated with L. plantarum and L. brevis showed a decreasing trend. Previous researches conducted in vitro have shown that ETEC can reduce the amounts of occludin in Small Intestinal Epithelial Cell Line- (IPEC-) 1 enterocytes of piglets [36], the permeability of tight junctions in IPEC-J2 enterocytes of piglets [37], and dislocation of ZO-1 Caco-2 cells of human [38]. However, probiotics increased the expression of tight junction proteins such as ZO-1, caudin-1, and occludin to protect cells [36, 39]. In this experiment, claudin-1 and occludin decreased significantly after ETEC challenge, while ZO-1 also showed a decreasing trend in mice, indicating that ETEC destroyed the intestinal barrier in mice. In contrast, L. plantarum and L. brevis increased the expression of the tight junction protein in mice challenged by ETEC. And the protective effect of L. brevis on the barrier function of mice was slightly higher than that of L. plantarum. Lysozyme is a critical bacteriostatic protein that strongly inhibits gram-positive bacteria [40], and cryptidin has a significant therapeutic effect on mice infected with Salmonella Typhimurium [41]. Therefore, the increase of these two substances in mice treated with L. plantarum and L. brevis may inhibit the growth of pathogenic bacteria and protect the health of mice.

There are lots of microbiota in the intestinal ecosystem, which play a significant role in host immunity and disease prevention. Therefore, unstable intestinal ecology may cause many diseases, such as ulcerative colitis and chronic diarrhea [42, 43]. ETEC reduced the intestinal microbial diversity of mice, while L. plantarum and L. brevis restored it to the normal level. The PD-whole-tree index of mice treated with L. plantarum was significantly higher than that of mice only challenged by ETEC, but there was no significant difference in the Shannon index. However, the results of mice treated with L. brevis showed the opposite results. This indicates that these two probiotics have almost the same effect on the recovery of intestinal microbial diversity in mice.

Proteobacteria is known to be the most disease-related intestinal microorganism, causing metabolic diseases and intestinal inflammation [44–46]. In this phylum, most microorganisms are human pathogens. Our study found that both L. plantarum and L. brevis inhibited the increase of Proteobacteria caused by ETEC significantly and made it return to the normal level, thus reducing the risk of intestinal inflammation in mice. Both Clostridia and Epsilonproteobacteria are pernicious bacteria that can cause digestive tract diseases in children. Tissue infection and intestinal diseases are often caused when those two bacteria enter the body of humans and other animals [47, 48]. Clostridia is involved in the development of necrotizing enterocolitis, which is a digestive tract disease that can threaten the life of preterm neonates [47]. In this study, mice treated with L. plantarum and L. brevis decreased the abundance of Clostridia and Epsilonproteobacteria, as well as a lower risk of digestive tract disease. As we all know, Lactobacillus is a probiotic with the function of preventing infection, reducing incidences of diarrhea, and improving production performance [49]. Some microorganisms of this genus, such as Lactobacillus rhamnosus and Lactobacillus reuteri, can protect the tight junctional protein after infection and contribute to the gut barrier function [50, 51]. In this experiment, both L. plantarum and L. brevis increased the abundance of Lactobacillus significantly, which may contribute to the gut barrier function and protection against inflammation. Helicobacter is the most common source of infection in the world, and it is the main risk factor of gastric cancer. Due to the ability to adapt to extreme acidic environment, Helicobacter can establish persistent infection and relieve the regulatory function of the host, leading to the pathogenesis and cancer of the digestive tract [52]. L. plantarum and L. brevis inhibited the growth of such pathogenic bacteria significantly and reduced the risk of canceration in tissue. It can be seen from the results that there is no significant difference between L. plantarum and L. brevis in promoting the abundance of probiotics and inhibiting that of pathogenic bacteria, indicating that they have almost the same effects on inhibiting intestinal inflammation and canceration.

5. Conclusion

The results in this experiment showed that L. plantarum and L. brevis can prevent the weight loss and intestinal injury caused by ETEC effectively, reduce the production of inflammatory factors, and strengthen the intestinal barrier function. Moreover, both of these two probiotics can stabilize the microbial community structure of intestine in mice, increase the abundance of probiotics such as Lactobacillus, and reduce the abundance of pathogenic bacteria such as Proteobacteria, Clostridia, Epsilonproteobacteria, and Helicobacter. Therefore, L. plantarum and L. brevis showed similarly effective inhibition on intestinal injury induced by ETEC and the ability to improve immune function. In summary, the feasibility and effectiveness of L. plantarum and L. brevis in the treatment of intestinal inflammation are demonstrated in our study, which provides a basis for further study of these two probiotics and their impact on intestinal inflammation such as diarrhea and colon cancer.

Data Availability

The data of this study is available from the correspondence authors upon reasonable request.

Conflicts of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

This research was supported by the National Natural Science Foundation of China (Nos. 31772642, 31672457, and 41807135), Local Science and Technology Development Project Guided by the Central Government (YDZX20184300002303), Hunan Provincial Science and Technology Department (2019TP2004, 2018WK4025, 2020NK2004, 2020ZL2004, 2016NK2101, 2016TP2005, and 2018CT5002), China Postdoctoral Science Foundation (2018M632963 and 2019T120705), Scientific Research Fund of Hunan Provincial Education Department (2020JGYB112 and 18B107), Double First-Class Construction Project of Hunan Agricultural University (SYL201802003, YB2018007, and CX20190497), and Natural Science Foundation of Hunan Province, China (No. 2019JJ50220).

References

K. M. Yang, Z. Y. Jiang, C. T. Zheng, L. Wang, and X. F. Yang, “Effect of Lactobacillus plantarum on diarrhea and intestinal barrier function of young piglets challenged with enterotoxigenic Escherichia coli K88,” Journal of Animal Science, vol. 92, no. 4, pp. 1496–1503, 2014.
View at: Google Scholar
J. M. Fairbrother, E. Nadeau, and C. L. Gyles, “Escherichia coli in postweaning diarrhea in pigs: an update on bacterial types, pathogenesis, and prevention strategies,” Animal Health Research Reviews, vol. 6, no. 1, pp. 17–39, 2005.
View at: Google Scholar
J. Guignot, C. Chaplais, M. H. Coconnier-Polter, and A. L. Servin, “The secreted autotransporter toxin, sat, functions as a virulence factor in Afa/Dr diffusely adhering Escherichia coli by promoting lesions in tight junction of polarized epithelial cells,” Cellular Microbiology, vol. 9, no. 1, pp. 204–221, 2007.
View at: Google Scholar
J. A. Guttman, Y. Li, M. E. Wickham, W. Deng, A. W. Vogl, and B. B. Finlay, “Attaching and effacing pathogen-induced tight junction disruption in vivo,” Cellular Microbiology, vol. 8, no. 4, pp. 634–645, 2006.
View at: Google Scholar
S. H. Kwak, Y. M. Cho, G. M. Noh, and A. S. Om, “Cancer preventive potential of kimchi lactic acid bacteria (Weissella cibaria, Lactobacillus plantarum),” Journal of cancer prevention, vol. 19, no. 4, pp. 253–258, 2014.
View at: Google Scholar
B. Le and S. H. Yang, “Efficacy of _Lactobacillus plantarum_ in prevention of inflammatory bowel disease,” Toxicology Reports, vol. 5, pp. 314–317, 2018.
View at: Publisher Site | Google Scholar
C. Stevenson, R. Blaauw, E. Fredericks, J. Visser, and S. Roux, “Randomized clinical trial: Effect of _Lactobacillus plantarum_ 299 v on symptoms of irritable bowel syndrome,” Nutrition, vol. 30, no. 10, pp. 1151–1157, 2014.
View at: Publisher Site | Google Scholar
P. Trevisi, R. Latorre, D. Priori et al., “Effect of feed supplementation with live yeast on the intestinal transcriptome profile of weaning pigs orally challenged with Escherichia coli F4,” Animal: an international journal of animal bioscience, vol. 11, no. 1, pp. 33–44, 2017.
View at: Google Scholar
G. Y. Yang, Y. H. Zhu, W. Zhang, D. Zhou, C. C. Zhai, and J. F. Wang, “Influence of orally fed a select mixture of Bacillus probiotics on intestinal T-cell migration in weaned MUC4 resistant pigs following Escherichia coli challenge,” Veterinary Research, vol. 47, no. 1, p. 71, 2016.
View at: Google Scholar
J. Villena, E. Chiba, M. G. Vizoso-Pinto et al., “Immunobiotic Lactobacillus rhamnosus strains differentially modulate antiviral immune response in porcine intestinal epithelial and antigen presenting cells,” BMC Microbiology, vol. 14, no. 1, p. 126, 2014.
View at: Publisher Site | Google Scholar
O. Farkas, G. Mátis, E. Pászti-Gere et al., “Effects of Lactobacillus plantarum 2142 and sodium n-butyrate in lipopolysaccharide-triggered inflammation: comparison of a porcine intestinal epithelial cell line and primary hepatocyte monocultures with a porcine enterohepatic co-culture system,” Journal of Animal Science, vol. 92, no. 9, pp. 3835–3845, 2014.
View at: Google Scholar
P. Yu, C. Ke, J. Guo, X. Zhang, and B. Li, “Lactobacillus plantarum L15 alleviates colitis by inhibiting LPS-mediated NF-κB activation and ameliorates DSS-induced gut microbiota dysbiosis,” Frontiers in Immunology, vol. 11, p. 575173, 2020.
View at: Google Scholar
R. Pieper, P. Janczyk, V. Urubschurov, U. Korn, B. Pieper, and W. B. Souffrant, “Effect of a single oral administration of Lactobacillus plantarum DSMZ 8862/8866 before and at the time point of weaning on intestinal microbial communities in piglets,” International Journal of Food Microbiology, vol. 130, no. 3, pp. 227–232, 2009.
View at: Google Scholar
J. Wang, H. F. Ji, S. X. Wang et al., “Lactobacillus plantarum ZLP001: in vitro assessment of antioxidant capacity and effect on growth performance and antioxidant status in weaning piglets,” Asian-Australasian Journal of Animal Sciences, vol. 25, no. 8, pp. 1153–1158, 2012.
View at: Google Scholar
M. Kassayová, N. Bobrov, L. Strojný et al., “Anticancer and immunomodulatory effects of Lactobacillus plantarum LS/07, inulin and melatonin in NMU-induced rat model of breast cancer,” Anticancer Research, vol. 36, no. 6, pp. 2719–2728, 2016.
View at: Google Scholar
L. O. Chuah, H. L. Foo, T. C. Loh et al., “Postbiotic metabolites produced by Lactobacillus plantarum strains exert selective cytotoxicity effects on cancer cells,” BMC Complementary and Alternative Medicine, vol. 19, no. 1, p. 114, 2019.
View at: Publisher Site | Google Scholar
E. Rönkä, E. Malinen, M. Saarela, M. Rinta-Koski, J. Aarnikunnas, and A. Palva, “Probiotic and milk technological properties of Lactobacillus brevis,” International Journal of Food Microbiology, vol. 83, no. 1, pp. 63–74, 2003.
View at: Google Scholar
R. Kant, J. Blom, A. Palva, R. J. Siezen, and W. M. de Vos, “Comparative genomics of Lactobacillus,” Microbial Biotechnology, vol. 4, no. 3, pp. 323–332, 2011.
View at: Google Scholar
N. Fuke, T. Takagi, Y. Higashimura et al., “Lactobacillus brevis KB290 with vitamin a ameliorates murine intestinal inflammation associated with the increase of CD11c+ macrophage/CD103- dendritic cell ratio,” Inflammatory Bowel Diseases, vol. 24, no. 2, pp. 317–331, 2018.
View at: Publisher Site | Google Scholar
N. Ueno, M. Fujiya, S. Segawa et al., “Heat-killed body of lactobacillus brevis SBC8803 ameliorates intestinal injury in a murine model of colitis by enhancing the intestinal barrier function,” Inflammatory Bowel Diseases, vol. 17, no. 11, pp. 2235–2250, 2011.
View at: Google Scholar
Y. Ma, C. Hu, W. Yan, H. Jiang, and G. Liu, “Lactobacillus pentosus increases the abundance of Akkermansia and affects the serum metabolome to alleviate DSS-induced colitis in a murine model,” Frontiers in cell and developmental biology, vol. 8, p. 591408, 2020.
View at: Publisher Site | Google Scholar
W. Ren, J. Yin, M. Wu et al., “Serum amino acids profile and the beneficial effects of L-arginine or L-glutamine supplementation in dextran sulfate sodium colitis,” PLoS One, vol. 9, no. 2, article e88335, 2014.
View at: Publisher Site | Google Scholar
Y. Ma, H. Jiang, J. Fang, and G. Liu, “IRW and IQW reduce colitis-associated cancer risk by alleviating DSS-induced colonic inflammation,” BioMed Research International, vol. 2019, Article ID 6429845, 9 pages, 2019.
View at: Publisher Site | Google Scholar
V. Liévin-Le Moal, “Dysfunctions at human intestinal barrier by water-borne protozoan parasites: lessons from cultured human fully differentiated colon cancer cell lines,” Cellular Microbiology, vol. 15, no. 6, pp. 860–869, 2013.
View at: Google Scholar
S. Ding, Y. Ma, G. Liu, W. Yan, H. Jiang, and J. Fang, “Lactobacillus brevis alleviates DSS-induced colitis by reprograming intestinal microbiota and influencing serum metabolome in murine model,” Frontiers in Physiology, vol. 10, p. 1152, 2019.
View at: Publisher Site | Google Scholar
V. Liévin-Le Moal and A. L. Servin, “The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota,” Clinical Microbiology Reviews, vol. 19, no. 2, pp. 315–337, 2006.
View at: Google Scholar
Y. Ma, G. Liu, M. Tang, J. Fang, and H. Jiang, “Epigallocatechin gallate can protect mice from acute stress induced by LPS while stabilizing gut microbes and serum metabolites levels,” Frontiers in Immunology, vol. 12, p. 640305, 2021.
View at: Publisher Site | Google Scholar
Y. Hou, L. Wang, W. Zhang et al., “Protective effects of N-acetylcysteine on intestinal functions of piglets challenged with lipopolysaccharide,” Amino Acids, vol. 43, no. 3, pp. 1233–1242, 2012.
View at: Google Scholar
H. Liu, J. Zhang, S. Zhang et al., “Oral administration of Lactobacillus fermentum I5007 favors intestinal development and alters the intestinal microbiota in formula-fed piglets,” Journal of Agricultural and Food Chemistry, vol. 62, no. 4, pp. 860–866, 2014.
View at: Google Scholar
C. Suo, Y. Yin, X. Wang et al., “Effects of lactobacillus plantarum ZJ316 on pig growth and pork quality,” BMC Veterinary Research, vol. 8, no. 1, p. 89, 2012.
View at: Publisher Site | Google Scholar
S. C. Tsai, M. Noda, R. Adamik, J. Moss, and M. Vaughan, “Enhancement of choleragen ADP-ribosyltransferase activities by guanyl nucleotides and a 19-kDa membrane protein,” Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 15, pp. 5139–5142, 1987.
View at: Google Scholar
X. Wang, X. Gao, and P. R. Hardwidge, “Heat-labile enterotoxin-induced activation of NF-κB and MAPK pathways in intestinal epithelial cells impacts enterotoxigenic Escherichia coli (ETEC) adherence,” Cellular Microbiology, vol. 14, no. 8, pp. 1231–1241, 2012.
View at: Google Scholar
L. Petecchia, F. Sabatini, C. Usai, E. Caci, L. Varesio, and G. A. Rossi, “Cytokines induce tight junction disassembly in airway cells via an EGFR-dependent MAPK/ERK1/2-pathway,” Laboratory investigation; a journal of technical methods and pathology, vol. 92, no. 8, pp. 1140–1148, 2012.
View at: Google Scholar
L. Huang, Z. Zhao, C. Duan et al., “Lactobacillus plantarum C88 protects against aflatoxin B1-induced liver injury in mice via inhibition of NF-κB-mediated inflammatory responses and excessive apoptosis,” BMC Microbiology, vol. 19, no. 1, p. 170, 2019.
View at: Publisher Site | Google Scholar
T. Lähteinen, A. Lindholm, T. Rinttilä et al., “Effect of _Lactobacillus brevis_ ATCC 8287 as a feeding supplement on the performance and immune function of piglets,” Veterinary Immunology and Immunopathology, vol. 158, no. 1-2, pp. 14–25, 2014.
View at: Publisher Site | Google Scholar
M. Roselli, A. Finamore, M. S. Britti et al., “The novel porcine Lactobacillus sobrius strain protects intestinal cells from enterotoxigenic Escherichia coli K88 infection and prevents membrane barrier damage,” The Journal of Nutrition, vol. 137, no. 12, pp. 2709–2716, 2007.
View at: Google Scholar
A. M. Johnson, R. S. Kaushik, and P. R. Hardwidge, “Disruption of transepithelial resistance by enterotoxigenic Escherichia coli,” Veterinary Microbiology, vol. 141, no. 1-2, pp. 115–119, 2010.
View at: Google Scholar
M. Roselli, A. Finamore, I. Garaguso, M. S. Britti, and E. Mengheri, “Zinc oxide protects cultured enterocytes from the damage induced by Escherichia coli,” The Journal of Nutrition, vol. 133, no. 12, pp. 4077–4082, 2003.
View at: Google Scholar
Y. Wu, C. Zhu, Z. Chen et al., “Protective effects of _Lactobacillus plantarum_ on epithelial barrier disruption caused by enterotoxigenic _Escherichia coli_ in intestinal porcine epithelial cells,” Veterinary Immunology and Immunopathology, vol. 172, pp. 55–63, 2016.
View at: Publisher Site | Google Scholar
T. Wu, Q. Jiang, D. Wu et al., “What is new in lysozyme research and its application in food industry? A review,” Food Chemistry, vol. 274, pp. 698–709, 2019.
View at: Google Scholar
P. Rishi, A. Bhogal, S. Arora, S. K. Pandey, I. Verma, and I. P. Kaur, “Improved oral therapeutic potential of nanoencapsulated cryptdin formulation against Salmonella infection,” European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences, vol. 72, pp. 27–33, 2015.
View at: Google Scholar
R. C. Vemuri, R. Gundamaraju, T. Shinde, and R. Eri, “Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?” Beneficial Microbes, vol. 8, no. 2, pp. 179–192, 2017.
View at: Google Scholar
I. Garcia-Mantrana, M. Selma-Royo, C. Alcantara, and M. C. Collado, “Shifts on gut microbiota associated to Mediterranean diet adherence and specific dietary intakes on general adult population,” Frontiers in Microbiology, vol. 9, p. 890, 2018.
View at: Publisher Site | Google Scholar
N. R. Shin, T. W. Whon, and J. W. Bae, “Proteobacteria: microbial signature of dysbiosis in gut microbiota,” Trends in Biotechnology, vol. 33, no. 9, pp. 496–503, 2015.
View at: Google Scholar
D. N. Frank, A. L. St Amand, R. A. Feldman, E. C. Boedeker, N. Harpaz, and N. R. Pace, “Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 34, pp. 13780–13785, 2007.
View at: Google Scholar
R. B. Sartor, “Microbial influences in inflammatory bowel diseases,” Gastroenterology, vol. 134, no. 2, pp. 577–594, 2008.
View at: Google Scholar
S. Schönherr-Hellec and J. Aires, “Clostridia and necrotizing enterocolitis in preterm neonates,” Anaerobe, vol. 58, pp. 6–12, 2019.
View at: Publisher Site | Google Scholar
O. Vandenberg, A. J. Cornelius, H. Souayah et al., “The role of Epsilonproteobacteria in children with gastroenteritis,” The Pediatric Infectious Disease Journal, vol. 32, no. 10, pp. 1140–1142, 2013.
View at: Google Scholar
J. F. Koninkx and J. J. Malago, “The protective potency of probiotic bacteria and their microbial products against enteric infections-review,” Folia Microbiologica, vol. 53, no. 3, pp. 189–194, 2008.
View at: Google Scholar
B. P. Blackwood, C. Y. Yuan, D. R. Wood, J. D. Nicolas, J. S. Grothaus, and C. J. Hunter, “Probiotic Lactobacillus species strengthen intestinal barrier function and tight junction integrity in experimental necrotizing Enterocolitis,” Journal of probiotics & health, vol. 5, no. 1, 2017.
View at: Google Scholar
F. Yang, A. Wang, X. Zeng, C. Hou, H. Liu, and S. Qiao, “Lactobacillus reuteri I5007 modulates tight junction protein expression in IPEC-J2 cells with LPS stimulation and in newborn piglets under normal conditions,” BMC Microbiology, vol. 15, no. 1, p. 32, 2015.
View at: Publisher Site | Google Scholar
V. Camilo, T. Sugiyama, and E. Touati, “Pathogenesis of Helicobacter pylori infection,” Helicobacter, vol. 22, Supplement 1, 2017.
View at: Google Scholar

Copyright

Copyright © 2021 Xuebing Han et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

983

Downloads

748

Citations